Pharmacy Diversion Awareness Conference
November 19-20, 2017; Radisson Hotel Manchester Downtown – Manchester, New Hampshire
The Drug Enforcement Administration (DEA) held a Pharmacy Diversion Awareness Conference (PDAC) on November 19-20, 2017 in Manchester, NH. The conference was developed and designed to address the growing problem of diversion of pharmaceutical controlled substances throughout the United States. In addition to pharmacy robberies and thefts, pharmaceutical controlled substances are often diverted by way of forged prescriptions, doctor shoppers, or illegitimate prescriptions from rogue practitioners. The objective of this conference was to educate pharmacists, pharmacy technicians, and pharmacy loss prevention personnel on ways to address and respond to potential diversion activity.
Over 175 pharmacists, pharmacy technicians, loss prevention personnel, and pharmaceutical students attended. The conference attendees received approximately seven hours of instruction on a variety of topics. The presentations included: Drug Trends, Drugs, Drugs and More Drugs, New Hampshire & Vermont Board of Pharmacy Update, CMEA Requirements for Retail Distributors, and Diversion Issues.
Select presentations from the Manchester PDAC, as well as a link to the Pharmacy Robbery & Burglary brochure, are below.
Drug Trends – Luis A. Carrion, Acting Unit Chief, Liaison Unit, Liaison and Policy Section, Diversion Control Division, DEA
Drugs, Drugs, and More Drugs – William T. Winsley, National Association of Boards of Pharmacy Representative
New Hampshire Board of Pharmacy – Michael Bullek, Administrator/Chief of Compliance, New Hampshire Board of Pharmacy
Vermont Board of Pharmacy – Carrie Phillips, Executive Officer, State of Vermont Pharmacy Board
CMEA Requirements for Retail Distributors – George Lutz, Diversion Investigator, Diversion Control Division, DEA
Medicare Pharmaceutical Diversion – Christy Wells, Operations Officer, Office of Inspector General, U.S. Department of Health and Human Services